The present invention relates to the use of immunogenic peptides comprising aT-cell epitope derived from an intracellularpathogen-associated antigen and a redox motif such as C-(X)2-[CST] or [CST]-(X)2-C in the prevention and/or treatmentof infection with an intracellular pathogen and in the manufacture ofmedicaments therefore.